Development of an Intranasal Vaccine To Prevent Urinary Tract Infection by Proteus mirabilis

類似資料

• Use of Translational Fusion of the MrpH Fimbrial Adhesin-Binding Domain with the Cholera Toxin A2 Domain, Coexpressed with the Cholera Toxin B Subunit, as an Intranasal Vaccine To Prevent Experimental Urinary Tract Infection by Proteus mirabilis
  著者:: Li, Xin, 等
  出版事項: (2004)
• Serum Immunoglobulin Response and Protection from Homologous Challenge by Proteus mirabilis in a Mouse Model of Ascending Urinary Tract Infection
  著者:: Johnson, David E., 等
  出版事項: (1999)
• Vaccination with Proteus Toxic Agglutinin, a Hemolysin-Independent Cytotoxin In Vivo, Protects against Proteus mirabilis Urinary Tract Infection
  著者:: Alamuri, Praveen, 等
  出版事項: (2009)
• Visualization of Proteus mirabilis Morphotypes in the Urinary Tract: the Elongated Swarmer Cell Is Rarely Observed in Ascending Urinary Tract Infection
  著者:: Jansen, Angela M., 等
  出版事項: (2003)
• Mannose-Resistant Proteus-Like Fimbriae Are Produced by Most Proteus mirabilis Strains Infecting the Urinary Tract, Dictate the In Vivo Localization of Bacteria, and Contribute to Biofilm Formation
  著者:: Jansen, Angela M., 等
  出版事項: (2004)